However there is evidence that the fraction of infiltrating immune cells, and more specifically lymphocytes, are associated with better prognosis in TNBC [222] as well as estrogen and progesterone receptor positive (ER+; PR+) breast cancer subtypes [223]. This evidence concerns the gene PGR and breast cancer.